High Dose Cyclophosphamide: Stem Cell Mobilizing Capacity in 21 Patients

References

• McCredie K. B., Hersh E. M., Freireich E. J. Cells capable of colony formation in the peripheral blood of man. Science 1971; 171: 293–294
   PubMed Web of Science ®Google Scholar
• Chervenick P. A., Boggs D. R. In vitro growth of granulocytic and mononuclear cells from blood of normal individuals. Blood 1971; 37: 131–135
   PubMed Web of Science ®Google Scholar
• To L. B., Shepperd M. K., Haylock D. N., Dyson P., Charles P., Thorp D. L., Dale B. M., Dart G. W., Roberts M. M., Sage R. E., Juttner C. A. Single high-dose of cyclophosphamide enable collection of high number of hemopoietic stem cell from the peripheral blood. Exp. Hematol. 1990; 18: 442–447
   PubMed Web of Science ®Google Scholar
• Cheson B. D., Lacema L., Leyland Jones B., Sarosy G., Wittes R. E. Autologous bone marrow transplantation. Current status and future directions. Ann. Intern. Med. 1989; 110: 51–65
   PubMed Web of Science ®Google Scholar
• Collins C., Mortimer J., Livingston R. B. High dose cyclophosphamide in the treatment of refractory lymphomas and solid tumor malignancies. Cancer 1989; 63: 228–232
   PubMed Web of Science ®Google Scholar
• Frei E., Canellos G. P. Dose: a critical factor in cancer chemotherapy. Am. J. Med. 1980; 69: 585–594
   PubMed Web of Science ®Google Scholar
• Brown R. A., Herzig R. H., Wolff S. N., Frei-Lahr D., Pineira L., Bolwell B. J., Lowder J. N., Horden E. A., Hande K. R., Herzig G. P. High-dose Etoposide and Cyclophosphamide without bone marrow transplantation for resistent hematologic malignancy. Blood 1990; 76(3)473–479
   PubMed Web of Science ®Google Scholar
• Gianni A. M., Bregni M., Siena S., Orazi A., Stern A. C., Gandola L., Bonadonna G. Recombinant human granulocyte-macrophage colony stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma. J. Clin. Oncol. 1990; 8(5)768–778
   PubMed Web of Science ®Google Scholar
• Korbling M., Darken B., Ho A. D., Pezzutto A., Hunstein W., Fliedner T. M. Autologous transplantation of blood derived haemopoetic stem cells after myeloablative therapy in a patient with Burkitt lymphoma. Blood 1986; 67: 529–532
   PubMed Web of Science ®Google Scholar
• Majolino I., Scimè R., Indovina A. Autologous blood stem cell transplantation in Hematologic malignancies. Haematologica 1990; 75: 55–66
   Google Scholar
• Kessinger A., Armitage J. O., Smith D. M., Landmark J. D., Bierman P. J., Weisenburger D. High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood 1989; 74(4)1260–1265
   PubMed Web of Science ®Google Scholar
• Bell A. J., Hamblin T. J., Oscier D. G. Circulating stem cell autografts. Bone Marrow Transplant 1986; 1: 103–110
   PubMed Web of Science ®Google Scholar
• Majolino I., Quaglietta A. M., Iacone A., Scime R., Fioritoni G., De Rosa L., Pierelli L., Indovina A., Spadano A., De Laurenzi A., Menichella G., For the Italian Cooperative Group for Cell Manipulation in Hematology. Autologous blood stem cell transplantation in malignant lymphomas: an Italian cooperative study. Int. J. Cell. Clon. 1992; 10(1)132
   Google Scholar
• Majolino I., Scime R., Indovina A., Vasta S., Patti C., Gentile S., Santoro A., Di Noto R., Fabbiano E., Guar-Naccia C, Felice R., Caronia F. Treatment of malignant lymphomas with very high dose CVB followed by transplantation of autologous blood stem cells collected after mobilizing chemotherapy. Haematologica 1991; 76(1)66–71
   PubMedGoogle Scholar
• To L. B. Assaying the CFU-GM in blood: correlation between cell dose and hemopoietic reconstitution. Proceedings of the International Symposium on peripheral blood stem cell autograts. Bone Marrow Transplant 1990; 5(1)16–18
   PubMedGoogle Scholar
• Lansdorp P. M., Sutherland H. J., Eaves C. J. Selective expression of CD45 isoforms on functional subpopulation of CD34+ hemopoietic cells from human bone marrow. J. Exp. Med. 1990; 172: 363–366
   PubMed Web of Science ®Google Scholar
• Siena S., Bregni M., Belli N., Ravagnani F., Gandola L., Stern A., Lansdorp P. M., Bonadonna G., Gianni A. M. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991; 77: 400–409
   PubMed Web of Science ®Google Scholar
• Buscemi F., Fabbiano F., Felice R., Di Noto R., Cappuzzo V., Majolino I., Caronia F. Use of large polygonal contigous gates for flow cytometry analysis of circulating progenitors cells. Bone Marrow Transplant 1993; 12: 305–306
   PubMed Web of Science ®Google Scholar
• Liberti G., Indovina A., Buscemi F., Gentile S., Scime R., Malleo C., Vasta S., Pampinella M., Cappuzzo V., Santoro A., Majolino I. Single intermediate-dose (4g/m2) cyclophosphamide and G-CSF for mobilization of circulating stem cells (CSC). Proc. 19th Annual Meeting of the EBMT. Garmish Partenkirchen, 1993, January 17–21, 1993. Abstract No. 3406.
   Google Scholar
• Carella A. M., Podesta M., Carlier P., Raffo M. R., Pollicardo N., Gualandi F. Conventional intensive therapy can lead to overshoot of ph-negative blood cells in chronic myeloid leukemia. Int. J. Cell. Clon. 1992; 10(1)117
   Google Scholar
• Vasta S., Santoro A., Barbara G., Indovina A., Gentile S., Tringali S., Majolino I. Poor circulating CFU-GM harvest and slow hematologic reconstitution in a patient with chronic granulocytic leukemia undergoing autologous transplantation. Bone Marrow Transplant 1991; 8: 327–329, letter
   PubMed Web of Science ®Google Scholar
• Jagannath S., Vesole D. H., Glenn L., Crowley J., Barlogie B. Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support. Blood 1992; 80: 1666–1672
   PubMed Web of Science ®Google Scholar
• Socinski M. A., Cannistra S. A., Elias A., Amman K. H., Schnipper L., Griffin J. D. Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet 1988; 1194–1198
   PubMed Web of Science ®Google Scholar
• De Luca E., Sheridan W. P., Watson D., Szer J., Begley C. G. Prior chemotherapy does not prevent effective mobilisation by G-CSF of peripheral blood progenitor cells. Br. J. Cancer 1992; 66: 893–899
   PubMed Web of Science ®Google Scholar
• Neben S., Marcus K., Mauch P. Mobilization of hematopoietic stem and progenitor cell subpopulation from the marrow to the blood of mice following cyclophosphamide and/or granulocyte colony-stimulating factor. Blood 1993; 81: 1960–1967
   PubMed Web of Science ®Google Scholar
• Molineaux G., Pojda Z., Hampson I. N., Lord B. I., Dexter T. M. Transplantation potential of peripheral blood stem cells induced by granulocyte colony-stimulating factor. Blood 1990; 76: 2153–2158
   PubMed Web of Science ®Google Scholar